These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7388861)

  • 1. Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusion.
    Brooks WW; Verrier RL; Lown B
    Cardiovasc Res; 1980 May; 14(5):295-302. PubMed ID: 7388861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sulfinpyrazone on ventricular vulnerability in the normal and the ischemic heart.
    Raeder EA; Verrier RL; Lown B
    Am J Cardiol; 1982 Aug; 50(2):271-5. PubMed ID: 7102558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion].
    Gülker H; Thale J; Brisse B; Bender F
    Z Kardiol; 1984 Aug; 73(8):515-24. PubMed ID: 6495811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extra-adrenergic mechanisms responsible for the effects of glucose-insulin-potassium solution on vulnerability to ventricular fibrillation.
    Brooks WW; Verrier RL; Lown B
    Am J Cardiol; 1981 Feb; 47(2):251-7. PubMed ID: 7008568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nitroglycerin on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion.
    Stockman MB; Verrier RL; Lown B
    Am J Cardiol; 1979 Feb; 43(2):233-8. PubMed ID: 104608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between sympathetic neural activity, coronary dynamics, and vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion.
    Lombardi F; Verrier RL; Lown B
    Am Heart J; 1983 Jun; 105(6):958-65. PubMed ID: 6858844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
    Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenaline, infused locally, reduces arrhythmia severity during coronary artery occlusion in anaesthetised dogs.
    Végh A; Parratt JR
    Cardiovasc Res; 2002 Jul; 55(1):53-63. PubMed ID: 12062708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of verapamil and bepridil on occlusion and reperfusion arrhythmias in the canine heart.
    Pelleg A; Pardo Y; Belhassen B; Shargordsky B; Chagnac A; Laniado S
    Cardiology; 1985; 72(4):193-201. PubMed ID: 3876883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute blood pressure elevation and ventricular fibrillation threshold during coronary occlusion and reperfusion in the dog.
    Blatt CM; Verrier RL; Lown B
    Am J Cardiol; 1977 Apr; 39(4):523-8. PubMed ID: 848436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
    Timour Q; Freysz M; Aupetit JF; Loufoua J; Frassati D; Faucon G
    Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcium blockers on ventricular fibrillation during acute myocardial infarction.
    Da-Luz PL; Da-Silveira MC; Murad-Neto A; Pileggi F
    Braz J Med Biol Res; 1988; 21(4):801-10. PubMed ID: 3266473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-arrhythmic effects of myocardial ischaemia. Relation to reperfusion arrhythmias?
    Podzuweit T; Binz KH; Nennstiel P; Flaig W
    Cardiovasc Res; 1989 Feb; 23(2):81-90. PubMed ID: 2550132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists and prevention of ventricular fibrillation induced by transient or persistent ischemia.
    Timour Q; Bui-Xuan B; Aupetit JF; Freysz M; Evreux JC; Faucon G
    Jpn Heart J; 1997 Mar; 38(2):237-51. PubMed ID: 9201111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericardial prostaglandin biosynthesis prevents the increased incidence of reperfusion-induced ventricular fibrillation produced by efferent sympathetic stimulation in dogs.
    Miyazaki T; Zipes DP
    Circulation; 1990 Sep; 82(3):1008-19. PubMed ID: 2118429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release.
    Corbalan R; Verrier RL; Lown B
    Am Heart J; 1976 Aug; 92(2):223-30. PubMed ID: 941834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular fibrillation in acute experimental myocardial ischemia: protection by magnesium sulfate.
    Barros LF; Da-Luz PL; Silveira MC; Chagas AC; Pileggi F
    Braz J Med Biol Res; 1988; 21(4):791-9. PubMed ID: 3240378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clonidine on vulnerability to fibrillation in the normal and ischemic canine ventricle.
    Rotenberg FA; Verrier RL; Lown B; Sole MJ
    Eur J Pharmacol; 1978 Jan; 47(1):71-9. PubMed ID: 618732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms involved in reperfusion arrhythmias.
    Verrier RL; Hagestad EL
    Eur Heart J; 1986 May; 7 Suppl A():13-22. PubMed ID: 3522236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vulnerability to ventricular fibrillation during acute coronary arterial occlusion and release.
    Axelrod PJ; Verrier RL; Lown B
    Am J Cardiol; 1975 Nov; 36(6):776-82. PubMed ID: 1199933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.